streptococcus vaccine

streptococcus vaccine

An obsolete vaccine prepared from Streptococcus species, formerly thought to be of use in preventing certain streptococcal infections.
References in periodicals archive ?
Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers.
Group B Streptococcus vaccine program licensed to Novartis - Intellectual property cross license agreement will allow Novartis to focus on vaccines and Intercell on therapeutic antibodies in this indication*
Early stage clinical trials for an injectable Meningitis B vaccine and a neonatal Group B Streptococcus vaccine are ongoing.
Emergent BioSolutions' product portfolio includes a drinkable Typhoid vaccine candidate, a Hepatitis B therapeutic vaccine candidate, Group B streptococcus vaccine candidate, a Chlamydia vaccine candidate, among others.
Completed a Phase I clinical trial for the company's group B streptococcus vaccine candidate;
This news release follows the Company's October 27, 1997 news release in which the Company announced that ID Vaccine Corporation, had entered into an agreement with the National Institutes of Health (NIH) for the initial human safety testing of ID Vaccine's group A streptococcus vaccine.
ID Biomedical Corporation (IDB) announced today that its group A streptococcus vaccine, being developed by its subsidiary ID Vaccine Corporation, has proven to be safe in recent experiments.
ID Biomedical Corporation (IDB) announced today that its proprietary group A streptococcus vaccine formulated for human use has demonstrated strong immune responses without toxicity during tests in an animal model.
Its lead products in clinical development are the FluINsure intranasal influenza vaccine and the StreptAvax group A streptococcus vaccine.
Dale is the inventor of UTRC's group A streptococcus vaccine technology.
Group A Streptococcus Vaccine Expected to Begin Testing in Children
9 /CNW-PRN/ - ID Biomedical Corporation (NASDAQ:IDBE) (TSE:IDB) announced today that results from human testing of its group A streptococcus vaccine, StreptAvax(TM), indicate the vaccine at the 50ug dose is safe and well tolerated.